期刊文献+

Preliminary study of photodynamic diagnosis using 5-aminolevulinic acid in gastric and colorectal tumors

Preliminary study of photodynamic diagnosis using 5-aminolevulinic acid in gastric and colorectal tumors
下载PDF
导出
摘要 AIM:To investigate the utility of photodynamic diagnosis(PDD) using 5-aminolevulinic acid(5-ALA) to detect gastric/colorectal tumors.METHODS:This prospective single-center study investigated inter-subject variability in patients with early-stage gastric/colorectal tumor indicated for endoscopic resection.Subjects were patients with gastric or colorectal tumors who had undergone endoscopic resection between November 2012 and November 2013.Selection criteria included age 20-80 years,either sex,and provision of informed consent.Patients were orally administered 20 mg/kg of 5-ALA enteric-coated capsules(SBI ALApromo Co.,Tokyo,Japan).Administration of5-ALA was followed by endoscopic resection of gastric or colorectal tumors,and the resected specimens were examined using a video autofluorescence processor and a fluorescence endoscope(SAFE-3000 and EB-1970 AK,respectively;Pentax,Tokyo,Japan).The primary endpoint was the presence of fluorescence in tumors.Endoscopic,macroscopic,and histopathologic findings of tumors were assessed.We also evaluated adverse events of the present procedure as a secondary endpoint and examined each patient for the presence of known adverse effects of 5-ALA,namely,hematocytopenia,liver dysfunction,hypotension,nausea,and photosensitivity.RESULTS:We enrolled 10 patients(7 men,3 women)(n = 13 lesions:10 gastric/3 colorectal tumors).Fluorescence was detected in 7/13(53.8%) lesions.No significant differences in sex(male:55.6%vs female:50.5%,P = 1.00),age(67.1 ± 1.9 years vs 65.0 ±2.0 years,P= 0.45),tumor color(reddish:60.0%vs discolored:33.3%,P = 0.56),tumor diameter(15.0± 2.1 mm vs 14.2 ± 2.3 mm,P= 0.80),macroscopic type(protruded:70.0%vs depressed 0%,P = 0.07),histologic type(differentiated type:58.3%vs 0%,P = 0.46),invasion depth(mucosal layer:55.6%vs submucosal layer:33.3%,P = 1.00),lymphatic invasion(present:33.3%vs absent:50.0%,P= 1.00),venous invasion(present:0%vs absent:54.5%,P= 1.00) or procedure time of endoscopic resection(36.3 ± 8.3 min vs 36.7 ± 9.0 min,P = 0.98) were observed between the patients with and without fluorescence.Fluorescence detection rate tended to be high for elevated lesions.Liver dysfunction developed in 4/10(40.0%) patients.The extent of the liver dysfunction was a slight increase in transaminases and total bilirubin levels,which spontaneously improved in the patients.None of the patients developed photosensitivity.CONCLUSION:Results of this preliminary study suggest the utility of PDD using 5-ALA for screening of gastric and colorectal cancers. AIM:To investigate the utility of photodynamic diagnosis(PDD) using 5-aminolevulinic acid(5-ALA) to detect gastric/colorectal tumors.METHODS:This prospective single-center study investigated inter-subject variability in patients with early-stage gastric/colorectal tumor indicated for endoscopic resection.Subjects were patients with gastric or colorectal tumors who had undergone endoscopic resection between November 2012 and November 2013.Selection criteria included age 20-80 years,either sex,and provision of informed consent.Patients were orally administered 20 mg/kg of 5-ALA enteric-coated capsules(SBI ALApromo Co.,Tokyo,Japan).Administration of5-ALA was followed by endoscopic resection of gastric or colorectal tumors,and the resected specimens were examined using a video autofluorescence processor and a fluorescence endoscope(SAFE-3000 and EB-1970 AK,respectively;Pentax,Tokyo,Japan).The primary endpoint was the presence of fluorescence in tumors.Endoscopic,macroscopic,and histopathologic findings of tumors were assessed.We also evaluated adverse events of the present procedure as a secondary endpoint and examined each patient for the presence of known adverse effects of 5-ALA,namely,hematocytopenia,liver dysfunction,hypotension,nausea,and photosensitivity.RESULTS:We enrolled 10 patients(7 men,3 women)(n = 13 lesions:10 gastric/3 colorectal tumors).Fluorescence was detected in 7/13(53.8%) lesions.No significant differences in sex(male:55.6%vs female:50.5%,P = 1.00),age(67.1 ± 1.9 years vs 65.0 ±2.0 years,P= 0.45),tumor color(reddish:60.0%vs discolored:33.3%,P = 0.56),tumor diameter(15.0± 2.1 mm vs 14.2 ± 2.3 mm,P= 0.80),macroscopic type(protruded:70.0%vs depressed 0%,P = 0.07),histologic type(differentiated type:58.3%vs 0%,P = 0.46),invasion depth(mucosal layer:55.6%vs submucosal layer:33.3%,P = 1.00),lymphatic invasion(present:33.3%vs absent:50.0%,P= 1.00),venous invasion(present:0%vs absent:54.5%,P= 1.00) or procedure time of endoscopic resection(36.3 ± 8.3 min vs 36.7 ± 9.0 min,P = 0.98) were observed between the patients with and without fluorescence.Fluorescence detection rate tended to be high for elevated lesions.Liver dysfunction developed in 4/10(40.0%) patients.The extent of the liver dysfunction was a slight increase in transaminases and total bilirubin levels,which spontaneously improved in the patients.None of the patients developed photosensitivity.CONCLUSION:Results of this preliminary study suggest the utility of PDD using 5-ALA for screening of gastric and colorectal cancers.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第21期6706-6712,共7页 世界胃肠病学杂志(英文版)
关键词 Photodynamic DIAGNOSIS 5-aminolevulinicacid PROTOPORPHYRIN IX GASTRIC TUMOR Colorectaltumor Photodynamic diagnosis 5-aminolevulinic acid Protoporphyrin IX,Gastric tumor Colorectal tumor
  • 相关文献

参考文献14

  • 1Lee HL, Eun CS, Lee OY, Han DS, Yoon BC, Choi HS, Hahm JS,Koh DH. When do we miss synchronous gastric neoplasms withendoscopy- Gastrointest Endosc 2010; 71: 1159-1165 [PMID:20381041 DOI: 10.1016/j.gie.2010.01.011].
  • 2Kato M, Kaise M, Yonezawa J, Yoshida Y, Tajiri H. Autofluorescenceendoscopy versus conventional white light endoscopy for thedetection of superficial gastric neoplasia: a prospective comparativestudy. Endoscopy 2007; 39: 937-941 [PMID: 18008201 DOI:10.1055/s-2007-966857].
  • 3Nokes B, Apel M, Jones C, Brown G, Lang JE. Aminolevulinicacid (ALA): photodynamic detection and potential therapeuticapplications. J Surg Res 2013; 181: 262-271 [PMID: 23510551 DOI:10.1016/j.jss.2013.02.002].
  • 4Ishizuka M, Abe F, Sano Y, Takahashi K, Inoue K, Nakajima M,Kohda T, Komatsu N, Ogura S, Tanaka T. Novel development of5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. IntImmunopharmacol 2011; 11: 358-365 [PMID: 21144919 DOI:10.1016/j.intimp.2010.11.029].
  • 5Japanese Gastric Cancer Association. Japanese gastric cancertreatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123[PMID: 21573742 DOI: 10.1007/s10120-011-0042-4].
  • 6Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, AjiokaY, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M,Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, OhkuraY, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, KoinumaN, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H,Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K,Sugihara K. Japanese Society for Cancer of the Colon and Rectum(JSCCR) guidelines 2010 for the treatment of colorectal cancer.Int J Clin Oncol 2012; 17: 1-29 [PMID: 22002491 DOI: 10.1007/s10147-011-0315-2].
  • 7Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, ReichO, Knuechel R, Baumgartner R, Tilki D, Popken G, HofstetterA, Stief CG. Photodynamic diagnosis of prostate cancer using5-aminolevulinic acid-first clinical experiences. Urology 2008; 72:345-348 [PMID: 18405945 DOI: 10.1016/j.urology.2007.12.086].
  • 8Haj-Hosseini N, Richter J, Andersson-Engels S, WardellK. Photobleaching behavior of protoporphyrin IX during5-aminolevulinic acid marked glioblastoma detection. Proc SPIE2009; 1: 7161 [DOI: 10.1117/12.808156].
  • 9Kiyotoki S, Nishikawa J, Okamoto T, Hamabe K, Saito M, GotoA, Fujita Y, Hamamoto Y, Takeuchi Y, Satori S, Sakaida I. Newmethod for detection of gastric cancer by hyperspectral imaging: apilot study. J Biomed Opt 2013; 18: 26010 [PMID: 23389679 DOI:10.1117/1.JBO.18.2.026010].
  • 10Tope WD, Ross EV, Kollias N, Martin A, Gillies R, Anderson RR.Protoporphyrin IX fluorescence induced in basal cell carcinomaby oral delta-aminolevulinic acid. Photochem Photobiol 1998;67: 249-255 [PMID: 9487802 DOI: 10.1111/j.1751-1097.1998.tb05194.x].

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部